IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,033,766 | +109.8% | 26,928 | +3.7% | 0.01% | +133.3% |
Q2 2023 | $492,670 | +48.1% | 25,971 | +21.1% | 0.00% | +50.0% |
Q1 2023 | $332,752 | -10.8% | 21,454 | +2.0% | 0.00% | -33.3% |
Q4 2022 | $373,229 | +252.1% | 21,027 | +10.6% | 0.00% | +200.0% |
Q3 2022 | $106,000 | +45.2% | 19,015 | +1.4% | 0.00% | – |
Q2 2022 | $73,000 | -34.2% | 18,746 | -7.0% | 0.00% | -100.0% |
Q1 2022 | $111,000 | -39.0% | 20,147 | -5.4% | 0.00% | 0.0% |
Q4 2021 | $182,000 | -4.7% | 21,305 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $191,000 | -14.0% | 21,942 | +4.4% | 0.00% | 0.0% |
Q2 2021 | $222,000 | -36.8% | 21,021 | -3.8% | 0.00% | 0.0% |
Q1 2021 | $351,000 | -65.1% | 21,853 | +0.3% | 0.00% | -75.0% |
Q4 2020 | $1,007,000 | +37.0% | 21,796 | +4.4% | 0.00% | 0.0% |
Q3 2020 | $735,000 | +157.9% | 20,876 | +78.6% | 0.00% | +300.0% |
Q2 2020 | $285,000 | – | 11,688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |